DE60302951D1 - Pyroglutaminsäure-salz von Amlodipin - Google Patents

Pyroglutaminsäure-salz von Amlodipin

Info

Publication number
DE60302951D1
DE60302951D1 DE60302951T DE60302951T DE60302951D1 DE 60302951 D1 DE60302951 D1 DE 60302951D1 DE 60302951 T DE60302951 T DE 60302951T DE 60302951 T DE60302951 T DE 60302951T DE 60302951 D1 DE60302951 D1 DE 60302951D1
Authority
DE
Germany
Prior art keywords
amlodipine
acid salt
pyroglutamic acid
chem
disclose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60302951T
Other languages
English (en)
Other versions
DE60302951T2 (de
Inventor
Yong Sik Youn
Seong Hwan Cho
Choong Sil Park
Yun Cheul Kim
Dong Kwon Lim
Sung Hak Jung
Sung Hak Lee
Hyun Suk Kang
Kyung Mi Park
Yun Taek Jung
Young Hoon Kim
Kyu Jeong Yeon
Myeong Yun Chae
Hae Tak Jin
Hea Ran Suh
Kwang Hyeg Lee
Hyuk Koo Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CJ CheilJedang Corp
Original Assignee
CJ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CJ Corp filed Critical CJ Corp
Application granted granted Critical
Publication of DE60302951D1 publication Critical patent/DE60302951D1/de
Publication of DE60302951T2 publication Critical patent/DE60302951T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE60302951T 2002-08-21 2003-08-20 Organisches Säuresalz von Amlodipine Expired - Lifetime DE60302951T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR2002049422 2002-08-21
KR10-2002-0049422A KR100467669B1 (ko) 2002-08-21 2002-08-21 암로디핀의 유기산염

Publications (2)

Publication Number Publication Date
DE60302951D1 true DE60302951D1 (de) 2006-02-02
DE60302951T2 DE60302951T2 (de) 2006-07-20

Family

ID=36643418

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60302951T Expired - Lifetime DE60302951T2 (de) 2002-08-21 2003-08-20 Organisches Säuresalz von Amlodipine

Country Status (9)

Country Link
US (1) US6846931B2 (de)
EP (1) EP1391453B1 (de)
JP (1) JP4319491B2 (de)
KR (1) KR100467669B1 (de)
CN (1) CN1289482C (de)
AT (1) ATE314349T1 (de)
AU (1) AU2003256108A1 (de)
DE (1) DE60302951T2 (de)
WO (1) WO2004018426A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042485A1 (en) * 2003-10-30 2005-05-12 Sk Chemicals, Co., Ltd. Acid added salts of amlodipine
DE102004025373A1 (de) * 2004-05-24 2005-12-15 Merck Patent Gmbh Maschinenlesbares Sicherheitselement für Sicherheitserzeugnisse
EP1695973A1 (de) * 2005-02-24 2006-08-30 Neuro3D Ocaperidonsalz und dieser enthaltende pharmazeutische Zubereitung
KR101501253B1 (ko) * 2014-12-22 2015-03-12 제이투에이치바이오텍 (주) 결정성 페북소스타트 피돌레이트 염 및 이의 제조 방법
CN104529877A (zh) * 2015-01-22 2015-04-22 华东理工常熟研究院有限公司 氨氯地平-癸酸离子液体及其制备方法和用途
US10695329B2 (en) 2016-10-07 2020-06-30 Silvergate Pharmaceuticals, Inc. Amlodipine formulations
PL3532457T3 (pl) * 2017-07-31 2020-10-19 Small Pharma Ltd Postacie krystaliczne hydroksynorketaminy
EP3773574A4 (de) 2018-04-11 2022-03-02 Silvergate Pharmaceuticals, Inc. Amlodipinformulierungen

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US86888A (en) * 1869-02-09 Improved clothes-pin
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
GB8710493D0 (en) 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US4758569A (en) 1987-08-26 1988-07-19 Pfizer Inc. Doxazosin as an anti-atherosclerosis agent
KR930006256B1 (ko) 1989-12-28 1993-07-09 주식회사 코오롱 폴리에스테르 결합제의 제조방법
US6057344A (en) 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
AT399718B (de) * 1992-04-16 1995-07-25 Lek Tovarna Farmacevtskih Inklusionskomplexe von optisch aktiven und racemischen 1,4-dihydropyridinen mit methyl-beta- cyclodextrin oder anderen cyclodextrinderivaten, ein verfahren zur herstellung von optisch aktiven dihydropyridinen und deren inklusionskomplexen und diese komplexe enthaltende pharmazeutische formulierungen
KR100188391B1 (ko) * 1993-08-27 1999-06-01 류정열 전기자동차의 충전중 표시 장치
KR100217240B1 (ko) * 1996-10-31 1999-09-01 조생현 암로디핀 베실레이트의 제조방법
PL189666B1 (pl) 1998-04-09 2005-09-30 Adamed Sp Z Oo Sposób otrzymywania benzenosulfonianu amlodypiny
JP3590966B2 (ja) 1999-02-22 2004-11-17 豊和工業株式会社 ロッドレスシリンダ
UA72768C2 (en) * 1999-07-05 2005-04-15 Richter Gedeon Vegyeszet A method for obtaining amilodipine benzenesulphonate
MXPA03005886A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Derivado de aspartato de amlodipina como antagonista del canal de calcio.
SI1309555T1 (sl) 2000-12-29 2005-12-31 Pfizer Ltd Postopek izdelave amlodipin-maleata
CA2433181C (en) 2000-12-29 2005-11-22 Pfizer Limited Amlodipine hemifumarate
KR100462304B1 (ko) 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염

Also Published As

Publication number Publication date
EP1391453B1 (de) 2005-12-28
US6846931B2 (en) 2005-01-25
CN1495166A (zh) 2004-05-12
DE60302951T2 (de) 2006-07-20
CN1289482C (zh) 2006-12-13
EP1391453A1 (de) 2004-02-25
AU2003256108A1 (en) 2004-03-11
JP4319491B2 (ja) 2009-08-26
KR20040017380A (ko) 2004-02-27
WO2004018426A1 (en) 2004-03-04
KR100467669B1 (ko) 2005-01-24
ATE314349T1 (de) 2006-01-15
JP2004131483A (ja) 2004-04-30
US20040158075A1 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
NO20040564L (no) Karboksylsyrederivatforbindelser og legemidler omfattende disse forbindelser som den aktive bestanddel
DK1086706T3 (da) Stabiliserede sammensætninger indeholdende nootropiske lægemidler
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
ATE296619T1 (de) Feste orale dosierungsform von simethicon
EE04799B1 (et) Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
DK1498411T3 (da) Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
DK1004578T3 (da) 5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
HK1067626A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
ATE454385T1 (de) Hiv-integrase-hemmers, pharmazeutischen zusammensetzung und ihre anwendung
SE0102440D0 (sv) New compound
MXPA02012889A (es) Esteres de acidos 4-alcoxi-ciclohexano-1-amino-carboxilicos y procedimiento para su obtencion.
WO2003024933A1 (fr) Derive d'acide 2-phenyle-3-heteroarylpropionique ou son sel et medicaments le contenant
EE200200591A (et) Püridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks ühenditeks
DE60302951D1 (de) Pyroglutaminsäure-salz von Amlodipin
ATE253359T1 (de) Antithrombotische mittel
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
DK1666473T3 (da) Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens
ATE286395T1 (de) Antithrombotische mittel
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
BR0313076A (pt) Sal de ácido orgânico de amlodipina
NO20041878D0 (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CJ CHEILJEDANG CORP., SEOUL, KR